| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 06/17/1992 | EP0490311A1 Derivatives of 10,11,12,13-tetra-hydrodesmycosin, processes for preparation, and use thereof in obtaining pharmaceuticals |
| 06/17/1992 | EP0490281A1 3'- Amino or thiolmodified, fluorescence coupled nucleoside and oligonucleotide, a method for their preparation and their use |
| 06/17/1992 | EP0436582A4 Phosphorothioate and normal oligodeoxynucleotides with 5'-linked acridine |
| 06/17/1992 | DE4039587A1 New derivs. of FR 520 and FK 506 - for treating transplant resistance, auto:immune diseases and inflammatory or hyper proliferative skin diseases |
| 06/16/1992 | US5122618 Insecticides and parasiticides |
| 06/16/1992 | CA2057651A1 Agistatins, novel metabolites from fusarium sp., a process for their preparation, and their use |
| 06/12/1992 | CA2057475A1 3'-(2')-amino- or thiol-modified, fluorescent dye-coupled nucleosides, nucleotides and oligonucleotides, and a process for the preparation and the use thereof |
| 06/11/1992 | WO1992009615A1 Method and means for oligonucleotide synthesis |
| 06/11/1992 | WO1992009604A1 6-azido-2-fluoropurine |
| 06/11/1992 | WO1991015498A3 Nucleoside derivatives |
| 06/11/1992 | DE4039060A1 New 6-cyclohexyl-2'-O-methyl-adenosine hydrate - has better purity and formulation characteristics than known mono:etherate |
| 06/10/1992 | EP0310645B1 Compounds useful particularly for radiotherapy or imaging of cancer |
| 06/09/1992 | US5120646 Process for the preparation of anthelmintive bioconversion products |
| 06/09/1992 | CA1303035C Delta _-ll-f28249 compounds |
| 06/09/1992 | CA1303034C Delta _-derivatives of ll-f28249 compounds |
| 06/09/1992 | CA1303033C Solution phase nucleic acid sandwich assay and polynucleotide probes useful therein |
| 06/09/1992 | CA1303032C2 Antiviral nucleosides |
| 06/09/1992 | CA1303031C Pyrimidine derivatives |
| 06/09/1992 | CA1303029C Parasiticides and insecticides |
| 06/08/1992 | CA2056967A1 Use of organic compounds |
| 06/07/1992 | WO1992010092A1 Very large scale immobilized polymer synthesis |
| 06/07/1992 | CA2097708A1 Very large scale immobilized polymer synthesis |
| 06/03/1992 | EP0488336A1 2-Substituted adenosine derivatives and pharmaceutical compositions for circulatory diseases |
| 06/03/1992 | EP0487719A1 Process for the preparation of 9-beta-d-arabinofuranosyl-2-fluoroadenine 5'-phosphate |
| 06/03/1992 | EP0487623A1 Derivatives of 5-amino-1,2,3,4 tetrahydro-acridine and applications as drugs |
| 06/03/1992 | EP0487593A1 Macrocyclic compounds |
| 06/02/1992 | US5118820 Difluro antivirals and intermediate therefor |
| 06/02/1992 | US5118672 5'-diphosphohexose nucleoside pharmaceutical compositions |
| 06/02/1992 | US5118601 Stabilization of mast cells by suppresion of mast cell activation |
| 06/02/1992 | CA1302407C Process for the preparation of macrolide compounds |
| 06/02/1992 | CA1302264C Therapeutic agent for skin ulcers |
| 06/02/1992 | CA1302263C Therapeutic nucleosides |
| 05/31/1992 | WO1992009276A1 Aromatic aldehydes and derivatives and pharmaceutical compositions thereof useful for the treatment of skin diseases and arthritis |
| 05/31/1992 | CA2095334A1 Pharmaceutical compositions |
| 05/29/1992 | WO1992008727A1 L-2'-desoxyuridines and pharmaceutical compositions containing them |
| 05/26/1992 | US5116968 Macrolide compounds |
| 05/26/1992 | CA1301751C Process for the preparation of a macrolide compound |
| 05/26/1992 | CA1301750C 13-deoxy-23-oxo(keto) and 23-imino derivatives of 13-deoxy c-076-aglycone compounds |
| 05/26/1992 | CA1301749C Macrolide compounds |
| 05/26/1992 | CA1301746C C(29)-oximinomilbemycin derivatives, process for their preparation and use as insecticides and parasiticides |
| 05/26/1992 | CA1301745C Macrolide antibiotics and their preparation |
| 05/26/1992 | CA1301686C Enzyme reactor with cofactor immobilized on a polymer |
| 05/26/1992 | CA1301652C Continuous intravenous infusion of adenosine to human patients |
| 05/20/1992 | EP0486477A2 1-( -D-Arabinofuranosyl)-5-propynyluracil as a VZV-antiviral compound |
| 05/20/1992 | EP0485517A1 Synthesis of glycosides having predetermined stereochemistry |
| 05/19/1992 | US5114931 Antilipemic agents, atheriosclerosis or antidepressants |
| 05/19/1992 | US5114930 Anthelmintics |
| 05/19/1992 | CA1301168C Process for producing macrolide compounds |
| 05/19/1992 | CA1301166C Process for preparing 2-deoxynucleosides |
| 05/19/1992 | CA1301164C 23-oxo (keto) and 23-imino derivatives of ll-f28249 compounds |
| 05/14/1992 | WO1992007570A1 Agents for the treatment of diseases caused by parasitic protozoa and neoplastic diseases |
| 05/14/1992 | WO1991016903A3 Use of purine derivatives for anesthesia, analgesia and in vivo organ preservation |
| 05/13/1992 | EP0485232A1 Neovascularisation inhibitors |
| 05/13/1992 | EP0485091A1 Process for the production of analogues of immunomycin |
| 05/13/1992 | EP0227844B1 Antiviral drug |
| 05/13/1992 | EP0214299B1 Preparation of 5-fluoro-2'-deoxyuridine esters for intraarterial administration |
| 05/12/1992 | US5112962 Oxalyl derivative provides quick release of product using mild conditions |
| 05/12/1992 | US5112854 Macrolide compounds |
| 05/12/1992 | US5112746 Fermentation of streptomyces |
| 05/12/1992 | CA1300617C Mono- and diepoxide derivatives of 23-deoxy-ll-f28249 compounds |
| 05/12/1992 | CA1300616C Mono- and diepoxide derivatives of ll-f28249 compounds |
| 05/12/1992 | CA1300614C 23-imino derivatives of 23-keto compounds |
| 05/12/1992 | CA1300609C 13-spiro-2'-¬tetrahydrofuran|-milbemycines, process for their preparation and their use against parasites and insect pests |
| 05/12/1992 | CA1300506C Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-beta-aldoglycosidyl) derivatives |
| 05/08/1992 | WO1992008456A2 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 05/08/1992 | CA2095732A1 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
| 05/06/1992 | EP0484199A1 Cosmetic use of an anti-erythema composition |
| 05/06/1992 | EP0484071A2 Synergism of HIV reverse transcriptase inhibitors |
| 05/06/1992 | EP0483130A1 Novel antitumor aldophosphamide analogs |
| 05/06/1992 | CN1060846A Macrocyclic compounds |
| 05/05/1992 | US5110926 Carbocyclic guanosine |
| 05/05/1992 | US5110919 Process for the preparation of 2-amino-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine and novel intermediates |
| 05/05/1992 | US5110811 Antibody inhibitors |
| 05/05/1992 | CA1300051C Phosphorylating reagents and method of using the same |
| 05/02/1992 | WO1992007867A1 Polysubstituted benzimidazoles as antiviral agents |
| 05/02/1992 | CA2100098A1 Polysubstituted benzimidazoles as antiviral agents |
| 05/02/1992 | CA2054529A1 Synergism of hiv reverse transcriptase inhibitors |
| 05/01/1992 | CA2054475A1 Composition with antierythemal activity and cosmetic use thereof |
| 04/30/1992 | WO1992006993A1 Novel ribonucleoside compounds, process for their preparation and drugs containing said compounds |
| 04/30/1992 | DE4033720A1 Protecting hydroxy gps. in polyfunctional cpds. - using allyl:sulphonyl gp. as blocking gp. |
| 04/30/1992 | CA2054128A1 Process for the production of analogues of immunomycin |
| 04/29/1992 | EP0482795A1 Preparation of novel invermectin compounds |
| 04/29/1992 | EP0482493A2 Pharmaceutical compositions active in the therapy of neurological affections in aids patients, containing as an active principle at last one compound selected from the group consisting of S-adenosyl-L-methionine salt, 5-methyl-tetrahydrofolic acid, 5-formyltetrahydrofolic acid |
| 04/28/1992 | US5109126 Labels for detecting and monitoring enzymes |
| 04/28/1992 | US5108993 Pharmaceutical composition comprising zidovudine and inosiplex or components thereof for the treatment of aids-related syndromes |
| 04/28/1992 | US5108992 Macrolide compounds |
| 04/28/1992 | US5108754 Orthomolecular method of treating sickle cell disease |
| 04/22/1992 | EP0481672A1 5Beta- and 13beta ivermectin monoglucopyranosides |
| 04/22/1992 | EP0481214A1 Prodrugs of phosphonates |
| 04/21/1992 | US5106994 Agents and method of production thereof |
| 04/21/1992 | US5106962 Reacting nucleosides with viologens in the presence of base |
| 04/21/1992 | US5106837 Administering 2-halo-2'-deoxyadenosine such as cladribine; treating autohemolytic anemia |
| 04/21/1992 | US5106740 Reacting cofactor with thiophosgene, attaching to water soluble polymer |
| 04/21/1992 | US5106729 Replacing oxygen in polymer with sulfur, then complexing with metal; measuring difference in electroconductivity with tip of scanning probe microscope |
| 04/16/1992 | CA2053432A1 5-beta and 13-beta-ivermectin monoglucopyranosides |
| 04/16/1992 | CA2053431A1 Avermectins are produced from known microorganisms |
| 04/16/1992 | CA2053418A1 Preparation of novel ivermectin compounds |
| 04/15/1992 | EP0480713A1 Nucleoside antiviral and immunomodulating agents |
| 04/15/1992 | EP0480693A2 Avermectin degradation products and derivatives |
| 04/15/1992 | EP0480623A1 New halomacrolides and derivatives having immunosuppressive activity |